Equity Overview
Price & Market Data
Price: $16.97
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $218,102,752
Daily Volume: 0
Performance Metrics
1 Week: 9.77%
1 Month: -0.35%
3 Months: -8.17%
6 Months: -1.28%
1 Year: 12.53%
YTD: -8.07%
Company Details
Employees: 121
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.